US Patent Issued to Senju Pharmaceutical on Aug. 11 for "Agent for promoting corneal endothelial cell adhesion" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,672, issued on Aug. 11, was assigned to Senju Pharmaceutical Co. Ltd. (Osaka, Japan).

"Agent for promoting corneal endothelial cell adhesion" was invented by Noriko Koizumi (Kyoto, Japan), Shigeru Kinoshita (Osaka, Japan) and Morio Ueno (Kyoto, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides an agent for promoting adhesion of a corneal endothelial cell, containing a Rho kinase inhibitor, as well as a culture medium for a corneal endothelial cell, a solution for preservation of cornea, and a method of producing a corneal endothelial preparation, which includes culturing the corneal endothelial cell using the aforementioned...